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Abstract
The CD11b/CD18 integrin (complement receptor 3, CR3) is a surface receptor on monocytes, neutrophils, macrophages and
dendritic cells that plays a crucial role in several immunological processes including leukocyte extravasation and
phagocytosis. The minor allele of a non-synonymous CR3 polymorphism (rs1143679, conversation of arginine to histidine at
position 77: R77H) represents one of the strongest genetic risk factor in human systemic lupus erythematosus, with
heterozygosity (77R/H) being the most common disease associated genotype. Homozygosity for the 77H allele has been
reported to reduce adhesion and phagocytosis in human monocytes and monocyte-derived macrophages, respectively,
without affecting surface expression of CD11b. Herein we comprehensively assessed the influence of R77H on different CR3-
mediated activities in monocytes, neutrophils, macrophages and dendritic cells. R77H did not alter surface expression of
CD11b including its active form in any of these cell types. Using two different iC3b-coated targets we found that the uptake
by heterozygous 77R/H macrophages, monocytes and neutrophils was significantly reduced compared to 77R/R cells. Allele-
specific transduced immortalized macrophage cell lines demonstrated that the minor allele, 77H, was responsible for the
impaired phagocytosis. R77H did not affect neutrophil adhesion, neutrophil transmigration in vivo or Toll-like receptor 7/8-
mediated cytokine release by monocytes or dendritic cells with or without CR3 pre-engagement by iC3b-coated targets.
Our findings demonstrate that the reduction in CR3-mediated phagocytosis associated with the 77H CD11b variant is not
macrophage-restricted but demonstrable in other CR3-expressing professional phagocytic cells. The association between
77H and susceptibility to systemic lupus erythematosus most likely relates to impaired waste disposal, a key component of
lupus pathogenesis.
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Introduction
Complement receptor type 3 (CR3, also known as Mac-1,
CD11b/CD18, aMb2) is a heterodimeric transmembrane recep-
tor found on most immune cells including dendritic cells (DCs),
monocytes/macrophages, neutrophils and NK cells. A wide range
of ligands have been described for CR3, including complement
activation fragments (C3b/iC3b) [1], intravascular adhesion
molecule-1 (ICAM-1, CD154 [2]), fibrinogen [3], high mobility
group box protein 1 (HMGB-1) [4] and lipopolysaccharide (LPS)
[5]. CR3 has been shown to contribute to cell activation,
chemotaxis, cytotoxicity, phagocytosis [6,7] and tolerance induc-
tion [8].
Genome-wide association studies (GWAS) have shown that an
allelic variant of the alpha-chain, encoded by the ITGAM gene, is
associated with risk of developing systemic lupus erythematosus
(SLE) [9–11]. The strongest association between ITGAM and risk
of SLE is with the minor allele of a non-synonymous SNP,
rs1143679 (odds ratio 1.4–2.17), which converts the arginine at
amino acid position 77 to a histidine (R77H, minor allele
frequency of ,10% in European American individuals) [9–11].
This variant does not appear to increase the risk for other
autoimmune conditions, except for systemic sclerosis [12,13], for
which the association is much weaker [14]. Although the
possibility of other independent rare causal variant(s) within the
ITGAM gene cannot be ruled out with certainty, imputation-based
association results have confirmed that rs1143679 remains the
most promising candidate for causal association with SLE [13].
The rs1143679 SNP encodes the Mart alloantigen that can cause
alloimmune neutropenia in neonates [15]. Interestingly some anti-
Mart antibodies are able to interfere with Mac-1-dependent
adhesive properties of neutrophils and monocytes and to prime
neutrophils for the production of reactive oxygen species [15].
Structurally CD11b consists of five extracellular domains and a
small cytoplasmic domain. The extracellular part of the protein is
composed of seven 60 amino acid repeats that fold into a seven
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bladed beta-propeller and an inserted (I) domain of 200 amino
acids between beta-sheets 2 and 3 of the beta-propeller. Ligand
binding appears to take place in the I domain [16]. The R77H
polymorphism is within the beta-propeller domain and currently it
is unclear how it may affect ligand binding, particularly as the full
crystal structure of CR3 has not yet been resolved.
Two recent studies have reported that the lupus-associated
minor CD11b allele (77H) impairs phagocytosis and adhesion
[17,18]. The first study used only transfected cell lines expressing
the 77H and 77R variants, whilst the second study also analysed
ex-vivo human 77H/H cells and demonstrated functional pertur-
bations in monocytes/macrophages carrying the SLE-associated
allele. To define the in vivo significance of R77H we elected to
study the risk allele in heterozygosity as this is the genotype of the
vast majority of SLE patients [9–11] and to assess several CR3-
mediated activities in the major human CR3 expressing cell types:
monocytes, macrophages, neutrophils and DCs. Using this
systematic and comprehensive approach we found that the
lupus-associated 77H allele impairs the phagocytosis of iC3b-
coated particles but does not appear to affect other CR3-mediated
functions including neutrophil adhesion and in vivo transmigration.
CR3 activation through iC3b-coated targets inhibited to a certain
degree the TLR7/8-mediated pro-inflammatory cytokine release
by 77R/H monocytes but, unlike the report by Rhodes et al [18]
with 77H/H monocytes, this effect was not influenced by R77H.
Our data demonstrate that the 77H allele selectively influences
CR3-mediated phagocytosis. The removal of cell debris (waste
disposal) without causing either inflammation or triggering an
autoimmune response is an important physiological activity.
Abnormalities in waste disposal pathways have been associated
with lupus pathogenesis [19,20]. The robust genetic association
between the 77H allele and lupus susceptibility together with our
data demonstrating a reduction in phagocytosis by 77R/H-
expressing phagocytic cells strengthen the hypothesis that abnor-
malities in waste disposal pathways play a key role in lupus
pathogenesis.
Materials and Methods
Donors and samples
Peripheral blood samples were obtained by venepuncture of
healthy adult volunteers after obtaining informed written consent
in accordance with the Declaration of Helsinki. The study was
approved by the Hammersmith and Queen Charlotte’s & Chelsea
Research Ethics Committee (REC 2000/6000). DNA was
obtained using a buccal kit according to the manufacturer
instruction (Qiagen Ltd, UK). The rs1143679 variant of ITGAM
was genotyped by direct sequencing of the PCR amplicon (forward
primer: 59AGTGCGACTACAGCACAGGCTCAT39 and re-
verse: 59GAGACAAGGAGGTCTGACGGTGAA39). All the vol-
unteers were healthy with no history of autoimmune conditions.
Human cell isolation
All blood samples were treated in a similar manner and
processed promptly. All ex-vivo assays were performed using freshly
isolated cells from sex- and ethnicity-matched individuals, one
individual homozygous for the common allele (77R/R) paired
with one 77H/H or 77R/H subject. Human neutrophils (PMNs)
were isolated by dextran sedimentation and discontinuous plasma-
Optiprep gradients [21] followed by negative selection using a
custom antibody cocktail containing antibodies to CD36, CD2,
CD3, CD19, CD56, glycophorin A and beads (Stemcell Tech-
nologies, Vancouver, Canada) as previously described [22]. Cell
purity was consistently .95% as verified by flow cytometry
(CD16hiCD14negCD11b+) and cytospin. Monocytes were obtained
by density gradient separation coupled with a negative selection kit
for human monocytes as recommended by the manufacturer
(Miltenyi Biotec GmbH, Germany). Monocyte-derived macro-
phages (for simplicity abbreviated as macrophages) were generated
by culturing the cells for two days in RPMI-1640 medium
supplemented with 10% fetal calf serum (FCS), 2 mM L-
glutamine, 1% penicillin/streptomycin (Life Technologies, Grand
Island, NY) and 20 ng/ml recombinant human macrophage
colony stimulating factor (M-CSF) (PeproTech, Rocky Hill, NJ) as
described previously [23]. Monocyte-derived dendritic cells (DCs)
were generated by culturing monocytes for 5–6 days in RPMI
1640 medium, 10% FCS, 1% penicillin/streptomycin, 2 mM L-
glutamine, 100 ng/ml recombinant human granulocyte-macro-
phage colony stimulating factor (GM-CSF) (PeproTech) and
50 ng/ml recombinant human IL-4 (PeproTech). Every 2–3 days,
50% of the culture media was exchanged with fresh media.
Murine cells
C57BL/6 mice were obtained from Harlan UK. CD11b-
deficient mice (Itgam2/2) [24] were from Jackson Laboratory (Bar
Harbor, ME, USA) and were backcrossed on the C57BL/6
genetic background for 10 generations. All animals were handled
in accordance with institutional guidelines and procedures
approved by the UK Home Office in accordance with the
Animals (Scientific Procedures) Act 1986. Conditional-Hoxb8
immortalized myeloid precursors were generated from C57BL/6
and Itgam2/2 mice as previously described using a retrovirus
encoding an estrogen receptor binding domain Hoxb8 fusion
protein [25]. The Itgam2/2 myeloid precursors were further
transduced with pMXs-IZ vector containing the human CD11b
variants. The cDNA of the 77R CD11b allele was obtained from
OriGene Technologies (Rockville, MD, USA, SC315229, NM-
000632.2), whilst the lupus susceptible allele (77H) was obtained
by site-directed mutagenesis by changing the G at position 230 to
an A (R77H). Both alleles were checked by sequencing. As control
an empty vector was added to conditional-Hoxb8 immortalized
myeloid precursors generated from C57BL/6 Itgam2/2 cells. The
different Hoxb8 immortalized myeloid precursors were differen-
tiated in vitro into murine neutrophils or macrophage cell lines by
removing estrogen and resuspending the cells in the appropriate
differentiation medium [Opti-MEM, 10% v/v FCS, 2 mM L-
Glutamine, 1% Penicillin/Streptomycin and 30 mM-mercaptoeth-
anol supplemented with 20 ng/ml recombinant murine stem cell
factor (SCF) (PeproTech) and recombinant murine granulocyte
colony stimulating factor (G-CSF) (PeproTech) for the neutrophils;
RPMI 1640, 10% v/v FCS, 2 mM L-Glutamine, Penicillin/
Streptomycin, and 20 ng/ml recombinant murine M-CSF (Pe-
proTech) for the macrophages] as previously reported [25,26]. By
day 4, neutrophils routinely represented ,98% of the cells and
were identified by flow cytometry as Ly-6B.2highCD117low cells
and on cytospins by their typical nuclear morphology. By day 5,
90–98% of the macrophages expressed high levels of F4/80 [27].
Cell surface expression of the heterodimer (murine CD18/human
CD11b) was assessed by flow cytometry using the following
antibodies: anti-human CD11b (ICRF44) or anti-mouse CD11b
(M1–70), the latter cross-reacts with human CD11b.
Flow cytometry
Murine and human leukocytes were stained using standard
protocols in the presence of a saturating concentration of 2.4G2
mAb. The following antibodies were used: anti-mouse CD11b
(M1–70), anti-mouse Ly-6B.2 (7/4), anti-mouse CD117 (2B8),
anti-mouse F4/80 (BM8), anti-human CD11b (ICRF44 and D12),
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anti-human CD11b (active epitope) (CBRM1/5), anti-human
CD14 (61D3), anti-human CD16 (3G8), anti-human CD62L
(DREG56). Antibodies were purchased from BD Biosciences
Pharmingen (San Diego, CA) or eBioscience (San Diego, CA). In
some assays PMNs were stimulated with 25 nM phorbol myristate
acetate (PMA; Sigma) for 5, 10 and 15 min prior to the staining.
Data were acquired using a FACSCalibur (Becton-Dickinson,
Mountain View, CA) and analyzed using FlowJo software, version
7.6 (TreeStar, Ashland, OR).
Phagocytosis assays
CD11b-mediated phagocytosis was performed using human
and murine cells and using three types of iC3b-coated particles:
mouse apoptotic thymocytes, guinea pig red blood cells (gRBCs)
and fluoresbriteH carboxylate YG 1.5 mm microspheres. Apoptotic
thymocytes and gRBCs (TCS Bioscences, Buckingham, UK) were
washed three times in PBS/1%BSA and then resuspended to
1%v/v in PBS. These cell suspensions were incubated with
pHrodoTM Dye Succinimidyl Ester (1 mg/ml, Life Technologies,
Grand Island, NY) for 30 minutes at room temperature. After
three washes the cells were opsonised with mouse C5-deficient
serum at 37uC for 30 mins (gRBCs-miC3b) and resuspended to
1%v/v in culture medium. FluoresbriteH carboxylate micro-
spheres (Polysciences Inc, Warrington, PA) were resuspended (1/
200) in Krebs’ Ringers PBS-Glucose buffer with human iC3b
(20 mg/ml, Complement Technology Inc, USA) and incubated at
37uC for 30 mins. Human iC3b-coated beads were then washed
with PBS/1%BSA/EDTA and resuspended in culture medium
(1/400). For all experimental protocols the level of iC3b-
opsonisation was checked by flow cytometry using a biotinylated
polyclonal antibody that recognises human and mouse C3
fragments (Clone: 6C9, Cedarlane Labs, Ontario, Canada)
followed by streptavidin-PE (BD Biosciences Pharmingen). In
each phagocytic assay complement-opsonised particles were fed at
a 10:1 ratio to DCs (0.76105 cells/well), macrophages
(16105cells/well), PMNs (26105cells/well) or monocytes
(26105cells/well) in U-bottom wells. Cells were collected at
different time points as indicated in the result section and the
uptake quantified by flow cytometry. Phagocytosis was calculated
as % of cells that had internalised the iC3b-coated particles. Non-
opsonised particles were used as negative controls. In selective
experiments phagocytosis was visualised using ImageStream
(Amnis, Seattle, WA). The data obtained were analyzed using
the ImageStream Data Exploration and Analysis Software
(IDEAS, Amnis). Single focused cells were gated by area aspect
ratio followed by gradient root mean square of the brightfield
image.
PMN – functional assays
Freshly isolated PMNs were assessed in several functional
assays:
i) Rosetting. Guinea pig RBCs were labelled with carboxy-
fluorescein diacetatesuccinimidyl ester (CFSE) as described
previously [28]. Different amounts of mouse or human
iC3b was deposited on the gRBCs by using increasing
dilution of mouse or human C5-deficient serum respec-
tively. Freshly isolated PMNs were washed and resupended
in 1 mM Mg2+/1 mM Ca2+ buffer and incubated with
gRBCs-iC3b for 30 min at 4uC with gentle shaking.
Rosetting was assessed by flow cytometry and on slide (at
least 200 PMNs analysed). PMN binding $3 RBCs was
recorded as a single rosette.
ii) Adhesion assays. Adhesion was measured by coating
Immunolon plates with fibrinogen (10 mg/ml). Plates were
blocked with PBS 1% BSA for 3 hr at room temperature.
Freshly isolated PMNs were then added (26105cells/well)
and incubated for 90 min at 37uC. Cells were gently
washed with Opti-MEM medium and adhesion assessed by
staining the adherent cells with crystal violet.
iii) Oxidative burst. Production of reactive oxygen species
(ROS) was studied by loading PMNs (105cells/ml) with 29,
79-dichlorodihydrofluorescin diacetate (DCFH-DA) (Sigma)
(5 mM) for 30 min at 37uC. After stimulation with PMA
(25 nM) for 30 min at 37uC, the increase in ROS
production was measured by flow cytometry.
iv) Neutrophil extracellular traps (NETs). PMNs seeded
at 105cells/well in complete medium (DMEM 10% v/v
FCS, 2 mM L-Glutamine, Penicillin/Streptomycin without
phenol red) were stimulated with 25 nM PMA (final
concentration) for 3 hours. Quantification was performed
as described previously [29].
v) In vitro chemotaxis assay. Chemotaxis assays were
performed as before [25]. Briefly, transwells (3 mm
polycarbonate membrane, 6.5-mm-diameter wells; Costar,
Corning, NY, USA), pre-treated with 2% (w/v) gelatin
(porcine skin type A; Sigma) were seeded with mouse
microvascular endothelial cells (36104/transwell) (kindly
donated by Prof F. Marelli-Berg, Imperial College London)
[30] or human umbilical vein endothelial cells (HUVEC)
(36104/transwell). After overnight culture, transwells were
washed, recombinant murine macrophage inflammatory
protein (MIP)-2 (PeproTech) was added to the bottom
chamber at a final concentration of 1 nM and 56105
neutrophils (murine neutrophil cell lines or freshly isolated
human PMNs) were added to the top chamber. At different
time points (from 30 to 120 minutes) cells were collected
from the bottom chamber for analysis. The number and the
viability of migrated cells were assessed by flow cytometry
by adding counting beads (Life Technologies) and by
staining the cells with propidium iodide.
vi) In vivo adoptive transfer model. In-vitro-differentiated
Itgam2/2 murine neutrophils reconstituted with one of the
human CD11b variants (mCD18/hCD11b-77R or
mCD18/hCD11b-77H) were labelled with either 1 mM
Cell Trace dodecyldimethylamine oxide succinimidyl ester
(DDAO) (Life Technologies) or 250 nM CFSE (Life
Technologies). DDAO- and CFSE-labelled neutrophils
(56106 of each type) were mixed in a 1:1 ratio in PBS
and injected i.v. into C57BL/6 mice. This was immediately
followed by an i.p. injection of 4% thioglycollate broth
(0.4 ml/mice, Sigma) or 330 nM MIP-2 (0.2 ml/mice,
PeproTech). PBS injection was used as control. Two hrs
after MIP-2 injection and 4 hours after the thioglycollate
injection, the mice were sacrificed and the peritoneal cells
were recovered by lavage with 5 ml of cold 5 mM EDTA
in HBSS. Total cell counts and differential analyses were
performed by flow cytometry.
Cytokine assays
Monocytes (26105 cells/well) and DCs (0.76105cells/well) were
incubated with iC3b-coated particles alone (gRBCs-miC3b or
hiC3b-coated beads). Non-opsonised particles and medium were
used as controls. In separate wells cells were pre-incubated for 1 hr
with hiC3b-coated beads and then stimulated with R848 (Life
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Technologies) (2 mg/ml or 10 mg/ml accordingly to the cell type).
Supernatants were collected after 24 hrs and frozen until analysis.
Cytokine levels were measured with a bead multiplex assay
(eBioscience) according to the manufacturer’s instructions. IL-1b,
IL-6, IL-10, IP-10, TNF-a were measured. Results were analysed
in two ways: i) the difference in cytokine production (expressed as
absolute value) between samples pre-incubated with coated
particles to samples pre-incubated with uncoated particle or
medium (as indicated in the figure legends) and ii) as % of change
induced by iC3b coated particle compared to medium or uncoated
particle. Both analyses gave statistically similar findings.
Statistics
Data are expressed as mean+/2SEM. Statistical analysis was
performed using GraphPad Prism version 3.0 (GraphPad
Software, San Diego, CA). Unless otherwise stated, data from in
vitro assays were analysed by two-tailed Student’s t-test for paired
samples. One-way analysis of variance with Bonferroni’s multiple
comparison tests were applied for analysis of multiple groups.
Differences were considered significant for p values,0.05.
Results
The lupus CD11b variant (77H) does not affect CD11b cell
surface expression
Due to the rarity of the minor allele (77H), the vast majority of
SLE patients are heterozygous (77R/H) and not homozygous for
the risk allele [11]. As a consequence, we elected to compare
healthy subjects that were homozygous for the non-risk allele
(77R/R) with healthy individuals carrying the risk allele in
heterozygosity (77R/H). However, for each assay we also
extended the analysis to three individuals that were homozygous
for the risk allele (77H/H). We did not detect any obvious
differences in these assays between 77R/H and the three 77H/H
samples. Therefore in representing our data we pooled the findings
obtained from the homozygous 77H/H and heterozygous 77R/H
individuals (77R/H-77H/H).
We initially assessed whether the 77H variant influenced
CD11b cell surface expression on resting cells. We measured
CD11b expression on PMNs, monocytes, macrophages and DCs
by flow cytometry using the ICRF44 antibody. Though the
CD11b expression varied among individuals there was no
genotype-specific difference (figure 1A). Similarly the analysis of
the active high affinity state of CD11b with the CBRM1/5
antibody failed to reveal any significant difference between the
77R/H and the 77R individuals (figure 1B). We also assessed how
quickly the two CD11b variants changed conformational state in
response to stimuli by performing a time course experiment with
PMNs activated with PMA (25 nM). The response of 77R/H
PMNs was similar to that of 77R/R PMNs (figure S1).
The CD11b risk allele leads to a defective uptake of
complement-coated particles without altering the
binding affinity for iC3b
CR3 is known to mediate phagocytosis of complement
opsonised microorganisms. We investigated whether the SLE-
associated allele affected this CR3-mediated function using two
different particles: gRBCs-miC3b and hiC3b-coated beads. The
use of gRBCs opsonised with mouse iC3b is likely to reduce the
strength of the receptor-ligand interaction allowing the detection
of subtle abnormalities, whilst the use of hiC3b-coated beads
minimises the confounding contribution of other phagocytic
mechanisms as the particles do not have other molecules expressed
on their surface and cannot release intracellular components.
gRBCs-miC3b were labelled with pHrodo that changes colour
when the particles are fused with the lysosome allowing us to
selectively quantify engulfed particles. In the assay with hiC3b-
coated bead ImageStream was used to confirm that the vast
majority (approximately 98%) of the positive cells had engulfed at
least one bead (data not shown). Using both iC3b-coated particles
we found that phagocytosis by 77R/H cells (macrophages, PMNs
and monocytes) was significantly less compared to the uptake by
the corresponding 77R/R cells (figure 2 and figure S2). The mean
values were statistically significant if the data were analysed as
either as percentage phagocytosis (figure 2) or as percentage
difference to 77R/R cells standardised to 100% in each assay
(macrophages after 30 min: 77R/R 100 vs 77R/H-77H/H
80.5+/25.8, p = 0.0054, 13 pairs; PMN after 15 minutes: 77R/
R 100 vs 77R/H-77H/H 83.9+/24.5, p= 0.0039, 13 pairs;
monocytes after 18 hrs: 77R/R 100 vs 77R/H-77H/H 90.0+/
23.6, p = 0.0315, 7 pairs). However, no genotype-specific defect in
phagocytosis was detected using DCs (% of phagocytosis after
1 hour: 100 in 77R/R vs 161.0+/228.0 in 77R/H-77H/H
individuals, p = 0.0608, 9 pairs).
Although in silico models indicate that the iC3b binding takes
place in the I domain and the 77R/H polymorphism is unlikely to
affect this binding site, we explored whether the differences
observed in phagocytosis were the result of different binding to
CR3. To address this issue in the most physiological ex-vivo setting
we used the traditional rosetting binding assay. Using this assay we
confirmed that the R77H polymorphism does not alter the binding
affinity for iC3b, at least on PMNs (figure 3). We also analysed the
adhesion of 77R/R and 77R/H-77H/H PMNs to plates coated
with fibrinogen and detected no differences between the two
genotypes (data not shown).
To circumvent all the technical limitations of using ex-vivo
human cells and to confirm that the impaired phagocytosis was
indeed specific to the R77H polymorphism and not due to another
independent variant(s) within the ITGAM gene or a gene closely
linked (e.g. ITGAX), we generated conditional-Hoxb8 immortal-
ized myeloid precursors from CD11b-deficient mice and trans-
duced them with either the 77R or 77H human CD11b variant.
The CD11b-transfected precursors were then matured into fully
differentiated macrophages or PMNs using the appropriate
conditional media [25,27]. Importantly, the immortalized cell
lines had similar cell surface expression of the hybrid CR3
molecule (mCD18/hCD11b-77R or mCD18/hCD11b-77H) (fig-
ure S3A). We then performed the same phagocytic and binding
assays applied to the human cells. The uptake of pHrodo loaded
gRBCs-miC3b by (mCD18/hCD11b-77H)-expressing macro-
phages was significantly reduced compared to the engulfment by
(mCD18/hCD11b-77R)-expressing macrophages (p = 0.0256),
mirroring the data obtained with the human cells (figure S3B).
A similar phagocytic defect was observed using opsonised
apoptotic cells, whilst the clearance of non-opsonised cells was
not affected by the expression of CD11b suggesting the
engagement of other receptors (figure S3C). Consistent with the
findings with ex-vivo human PMNs no differences were detected in
the percentage of gRBC-hiC3b bound to the immortalised
neutrophil cell lines expressing the hybrid CR3 molecules (figure
S3D).
In vivo and in vitro migration of neutrophils is not
affected by the 77R/H CD11b polymorphism
Given the technical hurdle of comparing resting neutrophils
isolated from different individuals we elected to use the
immortalised neutrophil cell lines to investigate whether the 77H
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Figure 1. Cell surface expression of CD11b on different cell populations. The expression was quantified by flow cytometry using ICRF44 (A)
and CBRM1/5 (B) antibodies. The latter only recognises the headpiece of CD11b in its active state. Data are presented in mean fluorescence intensity
(MFI), closed symbols 77R/R donors, open symbols 77R/H-77H/H donors. The two groups were not statistically different. Bars indicate means.
doi:10.1371/journal.pone.0057082.g001
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variant altered the ability of PMNs to migrate through an
endothelium layer. We initially measured the migration through a
mouse endothelium layer in response to MIP-2 using a transwell
assay and found no differences between the CD11b-deficient in
vitro-derived neutrophils reconstituted with either of the two hybrid
CR3 molecules (figure 4A). As previously reported [25], the
CD11b-deficient PMNs, used as negative controls, showed an
accelerated migration compared to the wild type PMNs. In
keeping with these findings we observed no genotype-specific
differences in the number of freshly isolated human neutrophils
migrating through a HUVEC layer in response to MIP-2
(figure 4B). As the transmigration assays were performed under
static conditions, we adopted a previously described peritonitis
model [25] to evaluate the behaviour of the cells in vivo. The in vitro
differentiated PMN cell lines expressing the 77H or 77R CD11b
variant were labelled with DDAO or CFSE and co-injected i.v. at
a 1:1 ratio into wild type C57BL/6 mice. Immediately after the
adoptive transfer, inflammation was induced in the peritoneum
either with thioglycollate or MIP-2 injected i.p. and the number of
DDAO- and CFSE-labelled neutrophils elicited into the perito-
neum assessed by flow cytometry at different time points. Using
this in vivo migration assay we found that the same number of
(mCD18/hCD11b-77R)- and (mCD18/hCD11b-77H)-expressing
PMNs accumulated in the peritoneum irrespective of the
inflammatory stimuli applied (figure 4C, 4D). As predicted the
presence of the hybrid CR3 molecule, regardless of the CD11b
variant transduced, decreased the number of PMNs in the
peritoneum compared to that of the PMN cell line lacking
CD11b (data not shown) confirming that an interaction between
the hybrid mCD18/hCD11b molecule and mouse endothelium
had occurred. No labelled neutrophils were recovered from the
peritoneal lavage of animals injected with PBS. We also explored
other typical PMN functions: R77H polymorphism failed to alter
the oxidative burst and netosis of PMNs after stimulation with
PMA (data not shown).
Figure 2. Phagocytosis of hiC3b-coated fluorescent beads. The uptake by macrophages (A), PMNs (B), monocytes (C) and DCs (D) was
quantified by flow cytometry and the data are represented as percentage of phagocytosis. Data are expressed as mean+/2SEM. Filled columns 77R/R
individuals, open columns 77R/H-77H/H individuals. Paired T test was applied and the p values are indicated.
doi:10.1371/journal.pone.0057082.g002
Figure 3. Rosetting assay. Percentage of rosettes formed by CFSE-
labelled RBC-hiC3b with freshly isolated PMNs from donors carrying the
susceptible allele (77H/H, open symbol) or the common allele (77R/R,
closed symbol). One representative assay out of 3 independent
experiments.
doi:10.1371/journal.pone.0057082.g003
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Modulation of cytokine secretion
There is evidence in the literature that CR3 can alter the
cytokine production by TLR-stimulated monocytes/macrophages
and DCs [31–35]. More recently the R77H CD11b polymorphism
has been shown to induce a different inhibitor effect on the
TLR7/8-mediated pro-inflammatory cytokine release by mono-
cytes [18]. We initially measured the cytokine secretion (IL-6, IL-
10, TNF-a, IP-10 and IL-1b) by monocytes and DCs after TLR7/
8 stimulation. The CD11b genotype did not influence the cytokine
response (figure 5A and 5B). We also analysed the cytokine
production after overnight stimulation with beads or hiC3b-coated
beads. Neither of them induced detectable cytokines demonstrat-
ing no endotoxin contamination (data not shown). We then
investigated whether the 77R/H monocytes and DCs down-
regulated less efficiently the pro-inflammatory response induced by
TLR7/8 activation as recently reported [18]. To this end, we
compared the cytokine production with/without pre-incubation
with hiC3b-coated beads and analysed the difference between the
two samples. In DCs the pre-incubation with hiC3b-coated beads
induced a strong up-regulation of IL-10 and TNF-a with a modest
down-modulation of IL-6 (figure 5D). The effect on IP-10 was
barely detectable. In monocytes, the pre-incubation with hiC3b-
coated particles resulted in a small increase of IL-10, a decrease in
TNF-a, whilst IL-6 and IP-10 remained largely unchanged. The
changes in IL-1b secretion were variable (figure 5C). More
importantly, in both cell types we found no statistically significant
differences between the two CD11b variants in the cytokine
modulation by iC3b-coated particles after TLR7/8 stimulation. In
selected experiments we also used iC3b-gRBCs to mirror more
closely the experimental conditions used by Rhodes et al [18].
Although we observed a slightly different cytokine pattern with a
stronger effect on IL-1b secretion, we failed to identify a genotype-
specific difference in monocyte cytokine responses (figure S4).
Similarly CR3 ligation by hiC3b-coated particles modified the
TLR9-mediated pro-inflammatory cytokine released by mono-
cytes but the effect was not modulated by the CD11b genotype
(data not shown).
Figure 4. In vitro and in vivo PMNmigration. (A) Migration of neutrophil cell lines through transwells seeded with mouse endothelial cells. PMNs
migrated into the bottom chamber in response to MIP-2 were counted at different time points as indicated. Pooled results from at least 4
independent experiments are presented as mean 6 SEM. Itgam2/2 and wild type C57BL/6 neutrophil cell lines were used as controls. CD11b-
deficient PMNs, known to have weaker endothelial interactions, migrated faster than the C57BL/6 and the hCD11b expressing cell lines (p,0.001 at
60 mns and p,0.05 at 90 mns). Statistical analysis by Bonferroni’s multiple comparison test. (B) Time course of the migration of freshly isolated
human 77R/R or 77R/H neutrophils through a HUVEC layer in response to MIP-2. Pooled results from at least 4 independent experiments are
presented as mean6 SEM. (C, D) In vivo peritoneal migration of hCD11b-77R and hCD11b-77H PMN cells lines following i.p. injection of MIP-2 (C) and
thioglycollate (D). The two hCD11b expressing PMN lines were labelled with DDAO or CFSE and adoptive transferred at a 1:1 ratio into C57BL/6 mice.
Absolute numbers of labelled PMNs recovered from the peritoneum are shown. Data of one out of at least 3 independent experiments are presented.
Bars indicate means.
doi:10.1371/journal.pone.0057082.g004
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Discussion
Several genes that exert their effect through relatively common
allelic variants have been shown to be associated with SLE by
GWA studies [9,10,36–41] One of most prominent susceptibility
factors for SLE was found to be a SNP (rs1143679) which confers
the R77H amino acid substitution in CD11b. The functional
effects of this variant remains elusive. By using a broad approach
(ex-vivo human cells and immortalized PMN and macrophage lines
expressing the hCD11b variants) and by analysing the main
human CR3 expressing cells (monocytes, neutrophils, macrophag-
es and DCs) herein we demonstrate that in these cells the lupus
susceptibility allele (77H) impairs only the uptake of hiC3b-coated
targets without altering other CR3-mediated functions including
TLR7/8-induced cytokine secretion and neutrophil extravasation.
These findings highlight the importance of minor functional
changes in genes controlling waste disposal mechanisms in lupus
pathogenesis.
Two recent reports have suggested that the CD11b lupus risk
allele causes an impaired adhesion/phagocytosis and abnormal
cytokine modulation after TLR7/8 stimulation in monocytes
[17,18]. In both studies the function of the risk allele was
compared to the non-risk allele using transfected cell lines or
homozygous individuals. However, as the lupus risk allele has a
frequency of only 9–11% in populations of European and African
descent [9–11], with a much lower frequency (,0.01) in Asian
Populations [39], the vast majority of the SLE patients are
heterozygous for the rs1143679 SNP: approximately 27% are
77R/H compared to ,3% 77H/H. Assuming a codominant
model the odds ratio was significantly increased for both the 77R/
H (1.63) and the 77H/H (4.64) genotypes [11]. Therefore in our
study we have deliberately elected to analyse healthy 77R/H
individuals as they mirror more closely the disease population. In
all the assays with ex-vivo human cells we have also included in the
analysis 3 homozygous 77H/H individuals whose cells consistently
behaved like the 77R/H cells showing that a single 77H allele was
Figure 5. Cytokine response. Monocytes (A), DCs (B) were stimulated with 2 mg/ml and 10 mg/ml of TLR7/8 ligand (R848) respectively for 24 h.
Cytokines quantified using a bead multiplex assay. Closed symbols: 77R/R cells, open symbols: 77R/H-77H/H cells. Each dot represents a single
individual, bars denote means. No significant differences between the two CD11b genotypes. Statistical analysis by paired t test. (C, D) Modulation of
TLR7/8-induced cytokine release by hiC3b-coated beads. Monocytes (C), DCs (D) were fed with hiC3b-coated beads one hour prior to R848
stimulation. The cytokine changes between the samples with and without CR3 pre-engagement with iC3b are shown with the p values indicated.
Data are expressed as mean+/2SEM. The cytokine responses of 77R/R cells (black column) and 77R/H-77H/H cells (white columns) were not
statistically different in paired assays. IL, interleukin; TNF-a, tumour necrosis factor alpha; IP-10, Interferon gamma-induced protein 10.
doi:10.1371/journal.pone.0057082.g005
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sufficient to induce the cellular abnormalities detected. Therefore,
though we recognise that by adopting this approach some subtle
differences between the two CD11b variants might have been
overlooked, we think that our data mirror more realistically the
modest magnitude of risk carried by the 77H Cd11b variant.
It has been postulated that lupus patients might have higher
surface expression of CD11b resulting in an increased cellular
infiltrate and amplified inflammation [41–43]. Consistent with the
findings reported by Rhodes et al [18] we failed to detect any
obvious difference between 77R/R and 77R/H-77H/H individ-
uals in the surface expression of CD11b including its active form
assessed by the CBRM1/5 antibody.
The position of the 77R/H polymorphism in the beta-propeller
domain predicts that it is unlikely to affect the iC3b binding site
[11,44]. In keeping with this prediction we found no defects in the
binding of 77H PMNs to iC3b-RBC in the rosetting assay [15,18].
We observed, however, a significant reduction in the uptake of
iC3b-coated targets (gRBC and beads) by neutrophils indicating
that phagocytosis is not simply a function of ligand/receptor
interaction, but entails several subsequent events in which CR3
may play a role. Not surprisingly the impaired phagocytosis was
also detected in 77R/H monocytes and macrophages but not in
immature DCs. We confirmed the specificity of the effect for the
77H variant using stably genetically-modified in vitro-derived
macrophage lines lacking CD11b or expressing variant-specific
CD11b molecules. Using the allele-specific macrophage cell lines
we were able to show that the lupus-associated 77H allele impaired
also the phagocytosis of iC3b-coated apoptotic cells, a defect seen
in macrophages from lupus patients [45,46]. Overall our data not
only provide further support to previous reports linking the 77H
variant to impaired phagocytosis [17,18] but significantly expand
previous observations by demonstrating that the impaired
phagocytosis associated with the 77H CD11b variant is not
macrophage-restricted.
CR3 is known to bind a large range of ligands and to contribute
to leukocyte extravasation. Previous reports [17,18] have shown
that the lupus CD11b allele reduces cell adhesion to several CR3
ligands, including ICAM-1, under static and/or flow conditions.
However, these data, obtained in part with transfected cells [17],
are hard to reconcile with the clinical observations of hypercel-
lularity present in injured tissue. To circumvent some of the
limitations of the previous assays we applied a novel in vivo
adoptive transfer approach [25]. We found no genotype-specific
difference in the migration of PMNs under two distinct
inflammatory stimuli casting doubts on some of the previous
findings [17,18] and demonstrating that the 77H allele is unlikely
to affect this CR3-mediated pathway.
There is a growing body of evidence demonstrating that
engagement of CD11b can mediate both positive and negative
regulation of TLR signalling with contradictory results accordingly
to the experimental conditions applied [31,32,34,47–49]. Under
our experimental conditions we could not replicate the genotype-
specific difference in the cytokine responses induced by TLR7/8
stimulation after CR3 ligation recently reported by Rhodes et al.
in monocytes [18]. In our assay pre-incubation of monocytes with
hiC3b-coated beads had a less striking effect on the TLR7/8-
induced cytokine release compared to that reported [18] with just
an appreciable, though variable, inhibitory effect on TNF-a
production. However, regardless of the degree of cytokine
inhibition, the 77H variant did not affect the cytokine response.
Though we recognise that the use of 77R/H cells could have
masked a potential difference, most likely the explanation for the
discrepancy between the studies lies in the different hiC3b-coated
targets used. We deliberately avoided using sheep RBCs for two
main reasons: i) sheep RBCs require opsonisation with rabbit anti-
sheep erythrocyte IgM and human serum, both potential source of
contaminants causing non-specific interactions/effects; ii) RBCs
can release several molecules including haemoglobin that is known
to bind to CD163 on monocytes/macrophages dampening the
inflammatory response [50–52]. Consistent with the explanation
that, at least to a certain degree, the CR3-mediated inhibitor effect
on the TLR7/8-induced pro-inflammatory cytokine was due to
the use of the RBCs, we observed a much stronger IL-1b
inhibition when we pre-incubated the monocytes with gRBC-
iC3b. However, we used guinea pig red blood cells that do not
require opsonisation with IgM for complement activation and our
cytokine pattern did not entirely replicate the one reported by
Rhodes et al. Interestingly in DCs we observed a marked
synergistic positive effect on IL-10 and TNF-a secretion that was
again comparable between 77R/R and 77R/H cells. Therefore
CR3 may well act as an important regulator of several TLR
signalling pathways including the TLR7/8 but the effect does not
appears to be influenced by the R77H amino acid substitution.
In summary our observations demonstrate that the CD11b
lupus-associated variant leads to an impaired phagocytosis of
complement-opsonised targets, including apoptotic cells, by
monocytes/macrophages and PMNs. A reduced clearance of
iC3b-coated targets might lead to increased tissue damage and
inflammation, providing a plausible explanation for the genetic
linkage identified by GWA studies. CR3 may also interact with the
Fc receptors on the surface of neutrophils/macrophages modu-
lating the effect of immune complex binding and this cross-talk
warrants further analysis. However, one should not ignore the fact
that CR3 is also expressed on NK and a subset of B cells, cell types
that have recently shown to contribute to SLE pathogenesis [53–
55] and the effect of the lupus CD11b allele on these cells remains
to be examined.
Supporting Information
Figure S1 Fold increase expression of CD11b on PMNs
after PMA stimulation. Cell surface expression of CD11b was
assessed by flow cytometry using two antibodies: ICRF44 and
CBRM1/5 (active state). Closed symbols indicate the 77R/R
donors, open symbols the 77R/H-77H/H donors. Data were
normalised to the MFI of the respective unstimulated PMN.
Pooled results from 3 experiments are presented as mean of fold
increase 6 SEM.
(TIF)
Figure S2 Phagocytosis of gRBCs-miC3b. Uptake by
macrophages (A) and PMNs (B) carrying one of the two CD11b
variants (77R/R closed columns, 77R/H-77H/H open columns).
gRBCs were labelled with pHrodo and the uptake was quantified
by flow cytometry. The data are represented as percentage of
phagocytosis (macrophages:18 pairs; PMN: 13 pairs). Data are
expressed as mean+/2SEM. Statistical analysis by paired T test.
(TIF)
Figure S3 Assays with Itgam2/2 cell lines reconstituted
with a hybrid CR3 molecule (mCD18/hCD11b-77R or
mCD18/hCD11b-77H). (A) Cell-surface expression of the
hybrid molecules quantified by flow cytometry using an anti-
human CD11b antibody (ICRF44). Data are presented for
macrophages and PMNs. Dotted line: CD11b-deficient cells
transduced with an empty vector; solid line: mCD18/hCD11b-
77R cells; dashed line: mCD18/hCD11b-77H; shaded histogram:
cells derived from wild type C57BL/6 mice. (B) Engulfment of
pHrodo-loaded gRBC opsonised with miC3b. The percentage of
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phagocytosis was determined by flow cytometry at one hour time
point. A significant difference between the two macrophage lines
expressing the hybrid CR3 molecule was detected (p = 0.0256).
The parental CD11b-deficient macrophages were used as negative
control to confirm the specificity for CR3 of the assay. Bars
indicate means. (C) Phagocytosis of opsonised (black column) or
non opsonised (empty column) pHrodo labelled murine apoptotic
thymocytes. The percentage of phagocytosis was determined by
flow cytometry at one hour time point. Pooled data of 5
independent experiments. Data were normalised to the C57BL/
6 cell line and are expressed as mean+/2SEM. Statistical analysis
by paired T test. (D) Rosetting assay with CFSE-labelled gRBC-
hiC3b. Percentage of neutrophils bound to CFSE-labelled gRBCs
was measured by flow cytometry. Square symbols: mCD18/
hCD11b-77R; triangle symbols: mCD18/hCD11b-77H; circle
symbols: wild type C57BL/6 neutrophils.
(TIF)
Figure S4 Cytokine response. Modulation of TLR7/8-
induced cytokine release by iC3b-gRBC. Monocytes were fed
with iC3b-gRBC or gRBC one hour prior to R848 stimulation.
The cytokine changes between the samples with and without CR3
pre-engagement are shown with the p values indicated. Data are
expressed as mean+/2SEM. The cytokine responses of 77R/R
cells (black column) and 77R/H-77H/H cells (white columns)
were not statistically different in paired assays. IL, interleukin;
TNF-a, tumour necrosis factor alpha; IP-10, Interferon gamma-
induced protein 10.
(TIF)
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